[{"NetIncomeLoss_1_Q2_USD":-12959000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"LiabilitiesNoncurrent_0_Q2_USD":1009000.0,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":-3000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":17900000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-691000.0,"Depreciation_2_Q2_USD":417000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q2_shares":114990.0,"AssetsCurrent_0_Q2_USD":205544000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":33054656.0,"OperatingLeaseExpense_2_Q2_USD":600000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":4857247.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":368000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":81000.0,"UnrecognizedTaxBenefits_0_Q2_USD":0.0,"CommonStockSharesIssued_0_Q2_shares":33212544.0,"Assets_0_Q2_USD":210214000.0,"ShareBasedCompensation_2_Q2_USD":2403000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":1642000.0,"OperatingLeaseExpense_1_Q2_USD":300000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":32976026.0,"GeneralAndAdministrativeExpense_2_Q2_USD":9563000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":15183000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":7968000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":1760000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":25000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":3000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":3000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":5044000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":223000.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":1585000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":201930000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":584000.0,"Liabilities_0_Q2_USD":6814000.0,"DefinedContributionPlanCostRecognized_1_Q2_USD":160000.0,"DefinedContributionPlanCostRecognized_2_Q2_USD":80000.0,"OperatingLeaseLiability_0_Q2_USD":1676000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":567000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":577000.0,"InterestReceivableCurrent_0_Q2_USD":9000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-25000.0,"CommonStockSharesOutstanding_0_Q2_shares":33212544.0,"RestrictedCashNoncurrent_0_Q2_USD":205000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1649000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-20417000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":1102000.0,"LiabilitiesCurrent_0_Q2_USD":5805000.0,"AccountsPayableCurrent_0_Q2_USD":904000.0,"NonoperatingIncomeExpense_2_Q2_USD":748000.0,"DeferredFinanceCostsCurrentNet_0_Q2_USD":77000.0,"NonoperatingIncomeExpense_1_Q2_USD":53000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":567000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":56000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0703,"AdditionalPaidInCapital_0_Q2_USD":285430000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":202135000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":40000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":2823000.0,"NetIncomeLoss_2_Q2_USD":-23998000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3528000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":84000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-20541000.0,"RestrictedCashAndCashEquivalents_0_Q2_USD":205000.0,"CommonStockSharesAuthorized_0_Q2_shares":300000000.0,"OperatingIncomeLoss_2_Q2_USD":-24746000.0,"OperatingIncomeLoss_1_Q2_USD":-13012000.0,"InvestmentIncomeInterest_2_Q2_USD":723000.0,"InvestmentIncomeInterest_1_Q2_USD":50000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":210214000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":2403000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":1649000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-82033000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1092000.0,"OperatingExpenses_1_Q2_USD":13012000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":2153000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.73,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.39,"ProfitLoss_2_Q2_USD":-23998000.0,"OtherLiabilitiesCurrent_0_Q2_USD":495000.0,"StockholdersEquity_0_Q2_USD":203400000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":691000.0,"OperatingExpenses_2_Q2_USD":24746000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":294000.0,"Ticker":"STOK","CIK":"1623526","name":"STOKE THERAPEUTICS, INC.","OfficialName":"Stoke Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"702726891.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]